Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.
The Journal of Urology ( IF 5.9 ) Pub Date : 2022-07-27 , DOI: 10.1097/ju.0000000000002740 Ian M McElree 1 , Ryan L Steinberg 2 , Alex C Martin 2 , Jordan Richards 2 , Sarah L Mott 3 , Paul T Gellhaus 2 , Kenneth G Nepple 2 , Michael A O'Donnell 2 , Vignesh T Packiam 2
The Journal of Urology ( IF 5.9 ) Pub Date : 2022-07-27 , DOI: 10.1097/ju.0000000000002740 Ian M McElree 1 , Ryan L Steinberg 2 , Alex C Martin 2 , Jordan Richards 2 , Sarah L Mott 3 , Paul T Gellhaus 2 , Kenneth G Nepple 2 , Michael A O'Donnell 2 , Vignesh T Packiam 2
Affiliation
Bacillus Calmette-Guérin (BCG) is currently recommended as adjuvant therapy following complete transurethral resection of bladder tumor for high-risk nonmuscle-invasive bladder cancer (NMIBC). In response to the BCG shortage, gemcitabine plus docetaxel (Gem/Doce) has been utilized at our institution in the BCG-naïve setting. We report the outcomes of patients with high-risk BCG-naïve NMIBC treated with Gem/Doce.
中文翻译：
序贯膀胱内吉西他滨和多西他赛治疗卡介苗-Guérin-Naïve 高危非肌肉浸润性膀胱癌。
目前推荐卡介苗 (BCG) 作为高危非肌层浸润性膀胱癌 (NMIBC) 膀胱肿瘤完全经尿道切除术后的辅助治疗。为了应对 BCG 短缺，我们的机构在 BCG 初治环境中使用了吉西他滨加多西他赛 (Gem/Doce)。我们报告了接受 Gem/Doce 治疗的高危 BCG 初治 NMIBC 患者的结果。
更新日期：2022-07-27
中文翻译：
序贯膀胱内吉西他滨和多西他赛治疗卡介苗-Guérin-Naïve 高危非肌肉浸润性膀胱癌。
目前推荐卡介苗 (BCG) 作为高危非肌层浸润性膀胱癌 (NMIBC) 膀胱肿瘤完全经尿道切除术后的辅助治疗。为了应对 BCG 短缺，我们的机构在 BCG 初治环境中使用了吉西他滨加多西他赛 (Gem/Doce)。我们报告了接受 Gem/Doce 治疗的高危 BCG 初治 NMIBC 患者的结果。
京公网安备 11010802027423号